Cargando…
Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma
Autor principal: | Pagès, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254669/ https://www.ncbi.nlm.nih.gov/pubmed/30515272 http://dx.doi.org/10.18632/oncotarget.26340 |
Ejemplares similares
-
The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma
por: Pagès, Gilles
Publicado: (2018) -
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
por: Buti, Sebastiano, et al.
Publicado: (2018) -
Correction: Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets
por: Kaplan, Joanna L., et al.
Publicado: (2018) -
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
por: Amin, Asim, et al.
Publicado: (2019) -
Correction: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Publicado: (2021)